NCT06140771View on ClinicalTrials.gov

A Clinical Study to Assess the Gingivitis Effects of Various Dentifrices

NACompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

February 6, 2022

Study Completion Date

February 6, 2022

Conditions
Gingivitis
Interventions
DRUG

0.76% Sodium Monofluorophosphate Dentifrice

Whole mouth brushing with a toothpaste, twice daily for the duration of the study.

DRUG

1.15% Sodium Monofluorophosphate Dentifrice

Whole mouth brushing with a toothpaste, twice daily for the duration of the study.

DRUG

0.454% Stannous Fluoride Dentifrice

Whole mouth brushing with a toothpaste, twice daily for the duration of the study.

DRUG

0.454% Stannous Fluoride Dentifrice

Whole mouth brushing with a toothpaste, twice daily for the duration of the study.

Trial Locations (1)

90602

UHRG, Whittier

All Listed Sponsors
lead

Procter and Gamble

INDUSTRY

NCT06140771 - A Clinical Study to Assess the Gingivitis Effects of Various Dentifrices | Biotech Hunter | Biotech Hunter